Sales lead for the Coronary and Renal Denervation portfolio across the Czech Republic, responsible for strategic account development, physician education, and commercial execution. Progressed rapidly from regional sales to full national responsibility, driving revenue growth and long-term key account partnerships.

Since 2025, leading the launch and market development of Renal Denervation therapy in the country — coordinating across hospitals, insurance companies, and international proctors to establish a completely new treatment pathway and expand patient access to innovative cardiovascular care.

Managed a portfolio of B2B customers across sales activities including pricing, ordering, and invoicing. Built and maintained partner relationships while representing the company in public tender processes.

Led a newly formed team of 20+ people through a rapid ramp-up, consolidating multiple order-processing roles into one. Responsible for escalations, prioritisation, and team performance during intensive growth.